Citi Starts Tocagen Inc. (TOCA) at Buy
Tweet
Share
E-mailGet Alerts TOCA Hot Sheet
Price: $1.26 --0%
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Citi analyst Robyn Karnauskas initiates coverage on Tocagen Inc. (NASDAQ: TOCA) with a Buy rating and a price target of $27.00.
The analyst is positive on the name ahead of brain cancer data and likes the innovative platform.
For an analyst ratings summary and ratings history on Tocagen Inc. click here. For more ratings news on Tocagen Inc. click here.
Shares of Tocagen Inc. closed at $9.75 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Milestone Pharmaceuticals (MIST) at Overweight
- Citi cuts TJX Companies rating to Neutral, lowers price target
- Trupanion, Inc. (TRUP) PT Raised to $29 at Stifel as Pets Best Rolls Off Business
Create E-mail Alert Related Categories
Analyst Comments, Hot New Coverage, New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
